Neurotrophic Keratopathy clinical trials at University of California Health
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
The objective of this study is to compare the safety and efficacy of RGN-259 to placebo for the treatment of Neurotrophic Keratopathy (NK)
Our lead scientists for Neurotrophic Keratopathy research studies include Weldon Haw, M.D..